SCHEMBL24710380

SCHEMBL24710380

c1cc(-c2ccc(N(c3ccc(-c4cccc5oc6ccccc6c45)cc3)c3ccc(-c4cccc5oc6c(-c7ccc(-c8ccc(N(c9ccc(-c%10ccc(-c%11cccc%12c%11sc%11ccccc%11%12)cc%10)cc9)c9ccc(-c%10cccc%11oc%12ccccc%12c%10%11)cc9)cc8)c8c7oc7ccccc78)cccc6c45)cc3)cc2)cc(-c2cccc3oc4ccccc4c23)c1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.41
▸ PRKDC P78527 5/20 0.37
▸ PIK3CD O00329 2/20 0.35
▸ PIK3CB P42338 2/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ BRDT Q58F21 1/20 0.35
▸ CDC14B O60729 1/20 0.31
▸ CDC14A Q9UNH5 1/20 0.31
▸ LIMK1 P53667 1/20 0.31
▸ PLA2G2A P14555 1/20 0.31
▸ PLA2G4A P47712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24710376 0.96 ALOX5 (0.39) ALOX5PRKDCPIK3CDPIK3CBBRD4
SCHEMBL26033586 0.94 ALOX5 (0.39) ALOX5PRKDCPIK3CDPIK3CBBRD4
SCHEMBL24710068 0.94 ALOX5 (0.38) ALOX5PRKDCPIK3CDPIK3CBBRD4
SCHEMBL24710228 0.92 ALOX5 (0.47) ALOX5PRKDCPIK3CDPIK3CBBRD4
SCHEMBL24710885 0.92 ALOX5 (0.35) ALOX5PRKDCBRDTCDC14BCDC14A
SCHEMBL26033551 0.89 ALOX5 (0.34) ALOX5PRKDCPIK3CDPIK3CBBRD4
SCHEMBL26513414 0.89 ALOX5 (0.41) ALOX5PRKDCPIK3CDPIK3CBBRD4
SCHEMBL26031655 0.89 ALOX5 (0.44) ALOX5PRKDCPIK3CDPIK3CBBRD4
SCHEMBL23237226 0.88 ALOX5 (0.43) ALOX5PRKDCPIK3CDPIK3CBBRD4
SCHEMBL17412440 0.87 ALOX5 (0.46) ALOX5PRKDCPIK3CDPIK3CBBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11744149-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-08-29 — — US disclosed
US-20220399505-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2022-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220399505-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE RER1, LEF1, MLX ALOX5 1467/4885PRKDC 4864/4885PIK3CD 4792/4885
US-11744149-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device RER1, LEF1, MLX ALOX5 1467/4885PRKDC 4864/4885PIK3CD 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback